Search Results for keywords:"Cancer Research"

The National Cancer Institute announced a series of closed meetings for the review and evaluation of grant applications and contract proposals. These meetings, scheduled from April to May 2025, are closed to the public to protect confidential information, including trade secrets and personal details. Each meeting will be held virtually, and various Scientific Review Officers will oversee the proceedings. The meetings aim to assess proposals related to cancer research, which are supported by the National Institutes of Health.

The National Cancer Institute has announced a change to the meeting dates and times for the Special Emphasis Panel on Informatics Technologies for Cancer Research. Originally scheduled for January 29, 2025, the meeting will now take place on February 6 and 7, 2025. The meeting will still be held at the National Cancer Institute in Rockville, Maryland, but it will be closed to the public. This update was officially recorded in the Federal Register on December 19, 2024.

The National Cancer Institute announced a virtual meeting of the Frederick National Laboratory Advisory Committee on February 23, 2021. The meeting will take place online from 1:00 p.m. to 5:00 p.m. and will focus on ongoing and new activities at the Frederick National Laboratory for Cancer Research. The public can watch the meeting via a videocast on the NIH website, and those needing special accommodations should contact Caron A. Lyman, Ph.D. Additionally, written comments can be submitted to the committee as detailed in the notice.

The National Cancer Institute has announced upcoming meetings focused on reviewing and evaluating grant applications, set to take place virtually on April 10-11, 2025. These meetings will be closed to the public to protect confidential information and personal privacy. They involve the National Cancer Institute Special Emphasis Panel, which aims to explore innovative technologies for cancer research. Interested parties can contact Jeffrey E. DeClue, the Scientific Review Officer, for further information.